Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett E Skolnick

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Gut|August 5, 2016
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trialMatthieu Allez, Brett E Skolnick, Maria Wisniewska-Jarosinska, et al.
Plos One|August 8, 2015
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with PsoriasisAlice B Gottlieb, James G Krueger, Mia Sandberg Lundblad, et al.
Blood|April 14, 2010
Exploratory study on the reversal of warfarin with rFVIIa in healthy subjectsBrett E Skolnick, David R Mathews, Naum M Khutoryansky, et al.
Anesthesia and Analgesia|September 6, 2011
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory studyBrett E Skolnick, Magdy Shenouda, Naum M Khutoryansky, et al.
Stroke|December 1, 2004
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhageStephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Neurosurgery|May 23, 2008
Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trialRaj K Narayan, Andrew I R Maas, Lawrence F Marshall, et al.
Journal of Neurotrauma|May 22, 2008
Progression of traumatic intracerebral hemorrhage: a prospective observational studyRaj K Narayan, Andrew I R Maas, Franco Servadei, et al.
Neurocritical Care|June 8, 2006
Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trialStephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Stroke|February 2, 2008
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhageMichael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
The New England Journal of Medicine|February 25, 2005
Recombinant activated factor VII for acute intracerebral hemorrhageStephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Gut|August 5, 2016
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trialMatthieu Allez, Brett E Skolnick, Maria Wisniewska-Jarosinska, et al.
Plos One|August 8, 2015
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with PsoriasisAlice B Gottlieb, James G Krueger, Mia Sandberg Lundblad, et al.
Blood|April 14, 2010
Exploratory study on the reversal of warfarin with rFVIIa in healthy subjectsBrett E Skolnick, David R Mathews, Naum M Khutoryansky, et al.
Anesthesia and Analgesia|September 6, 2011
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory studyBrett E Skolnick, Magdy Shenouda, Naum M Khutoryansky, et al.
Stroke|December 1, 2004
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhageStephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Neurosurgery|May 23, 2008
Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trialRaj K Narayan, Andrew I R Maas, Lawrence F Marshall, et al.
Journal of Neurotrauma|May 22, 2008
Progression of traumatic intracerebral hemorrhage: a prospective observational studyRaj K Narayan, Andrew I R Maas, Franco Servadei, et al.
Neurocritical Care|June 8, 2006
Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trialStephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Stroke|February 2, 2008
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhageMichael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
The New England Journal of Medicine|February 25, 2005
Recombinant activated factor VII for acute intracerebral hemorrhageStephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
Pageof 3